Abstract: A mirror unit 2 includes a mirror device 20 including a base 21 and a movable mirror 22, an optical function member 13, and a fixed mirror 16 that is disposed on a side opposite to the mirror device 20 with respect to the optical function member 13. The mirror device 20 is provided with a light passage portion 24 that constitutes a first portion of an optical path between the beam splitter unit 3 and the fixed mirror 16. The optical function member 13 is provided with a light transmitting portion 14 that constitutes a second portion of the optical path between the beam splitter unit 3 and the fixed mirror 16. A second surface 21b of the base 21 and a third surface 13a of the optical function member 13 are joined to each other.

Abstract: An apparatus for manufacturing a steel strip, includes: a first water tank part that stores cooling water for immersing and cooling a steel strip; a water cooling nozzle unit that is provided in the first water tank part and injects cooling water to a surface of the steel strip; a second water tank part connected to the first water tank part through a joining port; an opening and closing door that opens and closes the joining port; and a conveyance control part that conveys the water cooling nozzle unit such that the water cooling nozzle unit passes through the joining port and is positioned at either a cooling water injection position inside the first water tank part or a non-water cooling standby position inside the second water tank part.

Abstract: The present invention relates to promoters for differentiation into chondrocytes, chondrocyte proliferation promoter, and cartilaginous matrix production promoter, each containing a glycoside of liquiritigenin. According to the present invention, promoters for differentiation into chondrocytes, promoters for proliferation of chondrocytes, and promoters for cartilaginous matrix production, that are superior in the stability and safety, have a superior promoting action on differentiation into chondrocytes, a superior promoting action on proliferation of chondrocytes, and a superior promoting action on cartilaginous matrix production, and effective for regeneration of cartilage and further, prophylaxis or improvement of symptoms and diseases caused by the damage and inflammation of cartilage, or symptoms and diseases showing the loss of cartilage such as osteoarthritis and the like.

Abstract: The present disclosure relates to the field of therapeutic methods for treating a cancer using an ADC. The present disclosure also relates to the field of pharmaceutical products comprising the ADC for treating a cancer. More specifically, the ADC is composed of an anti-cadherin-6 (CDH6) antibody connected via a linker to an anticancer agent, such as topoisomerase I inhibitor, and the cancer may be resistant to chemotherapy.

Abstract: An apparatus includes a control device having a controller that obtains a first signal transmitted from a communication terminal connected to a first wireless relaying device. The controller also obtains a second signal transmitted from the communication terminal to a second wireless relaying device different from the first wireless relaying device. Based on a relationship between a signal strength of the second signal and a predetermined first threshold of a signal strength of the first signal, the controller changes the first threshold to a second threshold different from the first threshold. Based on a relationship between the second threshold and the signal strength of the first signal, the controller transmits, to the communication terminal, first information regarding connection switching.

Abstract: An access point includes a first communicator, a detector, and a controller. The first communicator wirelessly communicates with a communication terminal using a first channel among a plurality of channels. The detector detects a priority signal. The controller checks the plurality of channels to set a second channel from among the plurality of channels. The second channel is different from the first channel and satisfies a first condition. The controller instructs the detector to monitor the second channel for the priority signal. In a case where the first communicator has detected the priority signal in the first channel, the controller switches the first channel to the second channel.

Abstract: A communication relaying method includes receiving an analogue sound signal. The method also includes converting the received analogue sound signal into a digital sound signal. The method also includes packetizing the digital sound signal into a first IP packet. The method also includes receiving a second IP packet. The method also includes transmitting the first IP packet with priority over the second IP packet.

Abstract: A disinfection apparatus includes an installation member. The installation member includes a sealing member configured to seal a hole located in a ceiling, a nozzle configured to be placed in a ceiling space through the hole and spray a chemical solution to disinfect the ceiling space, a mount member configured to place the nozzle above the sealing member, and a fixing member configured to maintain a state in which the sealing member seals the hole.

Abstract: A wireless communication device comprising a communication unit configured to communicate with a wireless communication terminal using a first method to transmit data that is receivable by the wireless communication terminal or a second method, different from the first method, to transmit data that is simultaneously receivable by a plurality of wireless communication terminals including the wireless communication terminal, a processor, and a memory configured to store a program, the program being executable by the processor to cause processor to change a communication rate of the second method based on information indicating an amount of communications traffic of the second method in each of a plurality of unit periods of time is provided. Accordingly, an appropriate multicast transmission rate can be automatically determined.

Abstract: A communication relay device includes a plurality of wireless communication modules; a processor; and a memory configured to store a program, the program being executable by the processor to cause the processor to: acquire a designated bandwidth and internal information of the communication relay device; and set a number of wireless communication modules among the plurality of wireless communication modules to be used for communication by the communication relay device based on the designated bandwidth and the internal information of the communication relay device.

Abstract: A wireless communication device includes a processor; and a memory configured to store a program, the program being executed by the processor to cause the processor to: change a RADIUS reauthentication interval used by a RADIUS server based on a number of RADIUS reauthentication failures for each of a plurality of communication terminals connected to the wireless communication device, and a first threshold.

Abstract: A wireless transmitting device includes a receiving circuit configured to receive a reception frame from another device, and a transmitting circuit configured to transmit a broadcast transmission frame while the receiving circuit is not receiving the reception frame, and controls the transmitting circuit to delay transmission of the broadcast transmission frame for a waiting period that starts from an end of reception of the reception frame according to a frame type of the transmission frame, including a broadcast frame, a unicast frame, and a reception acknowledgement response frame, wherein the waiting period for the broadcast frame is shorter than the waiting period for the unicast frame and longer than the waiting period for the reception acknowledgement response frame.

Abstract: The present invention provides a preventing or improving agent that can favorably promote bone formation, is effective in preventing or improving osteoporosis or a decrease in bone strength, has high safety, and is suitable for long-term continuous ingestion or administration, by forming a bone remodeling accelerator comprising one or more kinds selected from the group consisting of flavanone and a glycoside thereof.

Abstract: An information extraction support device includes a receptor, a pattern generator, a data generator, and an output controller. The receptor receives input of a first training example for learning a model used in at least one of extraction of information and extraction of a relation between a plurality of pieces of information, and clue information indicating a basis on which the first training example is used for learning. The pattern generator generates a supervised pattern for generating a training example used for learning, using the first training example and the clue information. The data generator generates a second training example using the supervised pattern. The output controller outputs the second training example and the clue information that is used to generate the supervised pattern having generated the second training example.

Abstract: A wireless transmitting system acquires transmission data, sequentially transmits, by broadcast, a plurality of frames contained in the acquired transmission data, that are modulated by any of a plurality of modulation and coding schemes (MCSs) including a first MCS and a second MCS, and controls to transmit a first frame that is modulated by the first MCS based on the acquired transmission data and then to transmit a second frame that is modulated by the second MCS based on the acquired transmission data.

Abstract: A signal transmission device includes a first antenna, a second antenna, a demodulation device, and a fixing member. The first antenna transmits radio waves containing a signal modulated at a first frequency. The second antenna receives the radio waves containing the signal via a medium. The demodulation device demodulates the signal and connected to the second antenna. The fixing member fixes the first antenna and the second antenna to the medium.

Abstract: According to an embodiment, a design support system supports determination of a first design specification of a plant, the system including a memory and a hardware processor. The memory stores therein second design specifications of existing plants in association with first information related to a document(s) concerned with an existing plant. The hardware processor acquires a required specification which includes a part of elements of the first design specification and which indicates value of each element to be satisfied; identifies, based on second information in which an element(s) is/are associated with each condition, an element associated with a condition that matches the required specification; identifies a second design specification corresponding to the required specification based on the element identified; selects an element(s); and extracts, from the first information associated with the second design specification identified, a description related to the element selected.

Abstract: A pharmaceutical composition wherein an antibody-drug conjugate in which a drug-linker of the represented formula (wherein A represents a connecting position to an antibody) is conjugated to the antibody via a thioether bond and a kinase inhibitor (at least one selected from the group consisting of a CDK4/6 inhibitor, an mTOR inhibitor, a PI3K inhibitor, an AKT inhibitor, an ERK inhibitor, an MEK inhibitor, an RAF inhibitor, a CDK1 inhibitor, a CDK2 inhibitor, a CHK1 inhibitor, a WEE1 inhibitor, a PLK1 inhibitor, an Aurora kinase inhibitor, a Bcr-Abl inhibitor, an Src inhibitor, an EPH inhibitor, a VEGFR inhibitor, a KIT inhibitor, an RET inhibitor, a PDGFR inhibitor, an FGFR inhibitor, a BTK inhibitor, an FLT3 inhibitor, an ALK inhibitor, a JAK inhibitor, an MET inhibitor, a CSF-1R inhibitor, an NTRK inhibitor, an EGFR inhibitor, and an HER2 inhibitor) are administered in combination, and/or a method of treatment.

Abstract: A pharmaceutical composition, wherein an antibody-drug conjugate in which a drug-linker represented by the following formula (wherein A represents a connecting position to an antibody) is conjugated to the antibody via a thioether bond, and a PARP inhibitor are administered in combination, and/or a method of treatment, wherein the antibody-drug conjugate and a PARP inhibitor are administrated in combination to a subject.

Abstract: A gaming device comprises a control unit and a storage unit. The control unit is configured to sequentially display symbols included in a first set of a plurality of symbols comprising a specific symbol in each of a plurality of display areas to change displays of the symbols in the plurality of display areas, and stop the changes of the displays of the symbols at a predetermined timing; sequentially display symbols included in a second set of a plurality of symbols comprising the specific symbol in a higher proportion than in the first set of symbols in each of the plurality of display areas to change displays of the symbols in the plurality of display areas, and stop the changes of the displays of the symbols at a predetermined timing; and execute a predetermined performance when the symbols included in the second set of symbols are sequentially displayed.